LAW vs LFST vs ALKT

For growth investors, Alkami Technology, Inc.

(ALKT) is the stronger pick with 32. 9% revenue growth year-over-year, versus 8. 3% for CS Disco, Inc. (LAW). LifeStance Health Group, Inc. (LFST) offers the better valuation at 442. 5x trailing P/E (102. 7x forward), making it the more compelling value choice. Analysts rate LifeStance Health Group, Inc. (LFST) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Alkami Technology, Inc.

is actually cheaper at 23. 0x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Alkami Technology, Inc.

(ALKT) delivered a total return of -54. 9%, compared to -90. 3% for CS Disco, Inc. (LAW). Over 10 years, the gap is even starker: ALKT returned -58. 2% versus LAW's -90. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), CS Disco, Inc.

(LAW) is the lower-risk stock at 0. 67β versus Alkami Technology, Inc. 's 1. 23β — meaning ALKT is approximately 83% more volatile than LAW relative to the S&P 500. On balance sheet safety, LifeStance Health Group, Inc. (LFST) carries a lower debt/equity ratio of 13% versus 98% for Alkami Technology, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Alkami Technology, Inc.

(ALKT) is pulling ahead at 32. 9% versus 8. 3% for CS Disco, Inc. (LAW). On earnings-per-share growth, the picture is similar: LifeStance Health Group, Inc. grew EPS 113. 3% year-over-year, compared to -12. 2% for Alkami Technology, Inc.. Over a 3-year CAGR, ALKT leads at 29. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

LifeStance Health Group, Inc.

(LFST) is the more profitable company, earning 0. 7% net margin versus -28. 3% for CS Disco, Inc. — meaning it keeps 0. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LFST leads at 1. 8% versus -30. 7% for LAW. At the gross margin level — before operating expenses — LAW leads at 74. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Alkami Technology, Inc.

(ALKT) trades at 23. 0x forward P/E versus 102. 7x for LifeStance Health Group, Inc. — 79. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for LAW: 126. 4% to $9. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, CS Disco, Inc.

(LAW) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 67)). Both have compounded well over 10 years (LAW: -90. 0%, ALKT: -58. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (LAW (Technology) and LFST (Healthcare) and ALKT (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: LAW is a small-cap quality compounder stock; LFST is a small-cap quality compounder stock; ALKT is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.